GSK Investigational Site is a clinical research site located in Chapel Hill, North Carolina, United States 27599.
Crixeo Clinical Trials Trust Score: 30/100 (FAILING). This profile has not yet been claimed by the site owner.
GSK Investigational Site has participated in 93 clinical trials with 7 currently active.
Therapeutic areas: Lupus Nephritis, Infection, Human Immunodeficiency Virus, Epilepsy.
Sponsors: Human Genome Sciences Inc., a GSK Company, ViiV Healthcare, GlaxoSmithKline.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in North Carolina · View every site in Chapel Hill
Trust Score: 30/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
GSK Investigational Site has a Crixeo Trust Score of 30/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
GSK Investigational Site has 93 clinical trials on record, with 7 currently active. Their work covers Lupus Nephritis, Infection, Human Immunodeficiency Virus, Epilepsy.
GSK Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.